Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) Margin of Safety % (DCF Dividends Based) : 46.75% (As of Jun. 10, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Cheng Yi Pharmaceutical Co Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

As of today (2024-06-10), Zhejiang Cheng Yi Pharmaceutical Co's Predictability Rank is 3.5-Stars. Zhejiang Cheng Yi Pharmaceutical Co's intrinsic value calculated from the Discounted Dividend model is ¥8.65 and current share price is ¥6.89. Consequently,

Zhejiang Cheng Yi Pharmaceutical Co's Margin of Safety % (DCF Dividends Based) using Discounted Dividend model is 46.75%.

Competitive Comparison of Zhejiang Cheng Yi Pharmaceutical Co's Margin of Safety % (DCF Dividends Based)

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Cheng Yi Pharmaceutical Co's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhejiang Cheng Yi Pharmaceutical Co's Margin of Safety % (DCF Dividends Based) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Cheng Yi Pharmaceutical Co's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Zhejiang Cheng Yi Pharmaceutical Co's Margin of Safety % (DCF Dividends Based) falls into.

Zhejiang Cheng Yi Pharmaceutical Co Margin of Safety % (DCF Dividends Based) Calculation

Zhejiang Cheng Yi Pharmaceutical Co's Margin of Safety % (DCF Dividends Based) for today is calculated as

Margin of Safety % (DCF Dividends Based)	=	(Intrinsic Value: DCF (Dividends Based)	-	Current Price)	/	Intrinsic Value: DCF (Dividends Based)
	=	(12.94	-	6.89)	/	12.94
	=	46.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Dividend model with default parameters.

Zhejiang Cheng Yi Pharmaceutical Co Margin of Safety % (DCF Dividends Based) Related Terms

Thank you for viewing the detailed overview of Zhejiang Cheng Yi Pharmaceutical Co's Margin of Safety % (DCF Dividends Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Cheng Yi Pharmaceutical Co Ltd (SHSE:603811) » Definitions » Margin of Safety % (DCF Dividends Based)

Traded in Other Exchanges

N/A

Address

No. 118, Chemical Road, Dongtou District, Zhejiang Province, Wenzhou, CHN, 325700

Website

http://www.chengyipharma.com

Zhejiang Cheng Yi Pharmaceutical Co Ltd is a pharmaceutical company that produces capsules, injections, tablets, APIs, and pharmaceutical intermediates in China. Its main products include glucosamine hydrochloride raw materials and preparations, torasemide injection and capsules, Gastrodin raw materials, ribavirin and purine raw materials, and so on.

Executives

Ke Ze Hui	Director
Ren Bing Jun	Director
Yan Yi Yi	Director
Ceng Huan Qun	Director
Li Shi Sheng	Director
Qiu Ke Rong	Director
Lv Sun Zhan	senior management
Zhang Gao Qiao	Supervisors
Zhang Zhi Hong	senior management
Mao Li Ping	senior management
Zhuang Xiao Ping	Director
Lin Xin Chen	senior management
Shen Ai Lan	Director
Zhang Fu Fu	Supervisors

Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) Headlines

No Headlines